CMAP Plus Intervention for Self-harm in Individuals with Substance Use Disorder in Pakistan

Launched by PAKISTAN INSTITUTE OF LIVING AND LEARNING · Jul 25, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a new intervention called CMAP Plus, which is designed to help individuals in Pakistan who struggle with self-harm and substance use disorders. The main goal is to see if this culturally adapted program, which combines therapy techniques such as Cognitive Behavioral Therapy (CBT) and Motivational Interviewing, is acceptable and helpful for those dealing with these issues. The study will take place in six major cities across the country, and researchers will gather feedback from participants about their experiences with the CMAP Plus intervention.

To be eligible for the trial, participants must be at least 18 years old, have a diagnosis of substance use disorder, and have engaged in self-harming behaviors in the past three months. Participants should also have completed their detoxification process and be able to give informed consent. The study aims to recruit about 80 individuals from hospitals and addiction centers. Those who join can expect to receive support through the CMAP Plus program, and their feedback will help researchers understand its effectiveness and improve mental health care for others facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged 18 and above.
• • Individuals diagnosed with SUD on DSM-5 criteria of mental disorders.
• • Having episodes of self-harm in last three months defined as a deliberate act to harm one's own body including but not limited to self-cutting, self-biting, self-poisoning, self-scratching, self-burning, self-hitting, pulling hair etc. assessed by deliberate self-harm inventory.
• • Capable to give informed consent.
• • Those who have completed detoxification process.
• Exclusion Criteria:
• • Participants with DSM-5 criteria of mental disorder other than SUD; due to a general medical condition or dementia, delirium, schizophrenia, bipolar disorder, personality disorders, learning disability or any other condition to the extent that engagement in the intervention would not be possible, e.g. communication difficulties.
• • Unlikely to be available for outcome assessments (temporary residence).